Abstract
How cancers are characterized and treated has evolved over the past few decades. Major advances in genomics tools and techniques have revealed interlinked regulatory pathways of cancers with unprecedented detail. Early discoveries led to success with rationally targeted small molecules and more recently with immunomodulatory agents, setting the stage for precision oncology. However, drug resistance to every agent has thus far proven intractable, sending us back to fill the gaps in our rudimentary knowledge of tumor biology. Epigenetics is emerging as a fundamental process in every hallmark of cancer. Large-scale interrogation of the cancer epigenome continues to reveal new mechanisms of astounding complexity. In this review, I present selected experimental and clinical examples that have shaped our understanding of cancer at the molecular level. Translation of our collective erudition into revolutionary diagnostic and treatment strategies will advance the precision oncology paradigm.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 147-156 |
| Number of pages | 10 |
| Journal | Journal of Immunotherapy and Precision Oncology |
| Volume | 3 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2020 |
Keywords
- Cancer
- Epigenomics
- Epitranscriptomics
- Genomics
- Immune checkpoint inhibitors
- Immuno-oncology
- Molecular therapy
- Noncoding RNA
- Targeted therapy
ASJC Scopus subject areas
- Cancer Research
- Oncology
- Immunology
- Immunology and Allergy